Patents by Inventor Daqing W. Hartwell

Daqing W. Hartwell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR DIAGNOSING AND TREATING HEMOSTATIC DISORDERS BY MODULATING P-SELECTIN ACTIVITY
    Publication number: 20080193949
    Abstract: The present invention identifies P-selectin as a modulator of hemostasis. Accordingly, the present invention relates to methods for the identification and use of modulators of P-selectin activity as modulators of hemostasis. The invention also relates to methods and compositions for the diagnosis and treatment of hemostatic disorders, including, but not limited to, hemorrhagic disorders and thrombotic disorders. The present invention describes methods for the diagnostic evaluation and prognosis of various hemostatic conditions, and for the identification of subjects exhibiting a predisposition to such conditions. In addition, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of a hemostatic or vascular disorders, and for monitoring the efficacy of compounds in clinical trials.
    Type: Application
    Filed: February 13, 2008
    Publication date: August 14, 2008
    Applicant: Center for Blood Research
    Inventors: Denisa D. Wagner, Patrick Andre, Daqing W. Hartwell, Ingrid Hrachovinova
  • Methods of treating hemophilia or von willebrand disease with p-selectin
    Patent number: 7387777
    Abstract: The present invention identifies P-selectin as a modulator of hemostasis. Accordingly, the present invention relates to methods for the identification and use of modulators of P-selectin activity as modulators of hemostasis. The invention also relates to methods and compositions for the diagnosis and treatment of hemostatic disorders, including, but not limited to, hemorrhagic disorders and thrombotic disorders. The present invention describes methods for the diagnostic evaluation and prognosis of various hemostatic conditions, and for the identification of subjects exhibiting a predisposition to such conditions. In addition, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of a hemostatic or vascular disorders, and for monitoring the efficacy of compounds in clinical trials.
    Type: Grant
    Filed: February 19, 2004
    Date of Patent: June 17, 2008
    Assignee: Center For Blood Research, Inc.
    Inventors: Denisa D. Wagner, Patrick Andre, Daqing W. Hartwell, Ingrid Hrachovinova
  • Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity
    Publication number: 20040265311
    Abstract: The present invention identifies P-selectin as a modulator of hemostasis. Accordingly, the present invention relates to methods for the identification and use of modulators of P-selectin activity as modulators of hemostasis. The invention also relates to methods and compositions for the diagnosis and treatment of hemostatic disorders, including, but not limited to, hemorrhagic disorders and thrombotic disorders. The present invention describes methods for the diagnostic evaluation and prognosis of various hemostatic conditions, and for the identification of subjects exhibiting a predisposition to such conditions. In addition, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of a hemostatic or vascular disorders, and for monitoring the efficacy of compounds in clinical trials.
    Type: Application
    Filed: February 19, 2004
    Publication date: December 30, 2004
    Inventors: Denisa D. Wagner, Patrick Andre, Daqing W. Hartwell, Ingrid Hrachovinova
  • Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity
    Publication number: 20020031508
    Abstract: The present invention identifies P-selectin as a modulator of hemostasis. Accordingly, the present invention relates to methods for the identification and use of modulators of P-selectin activity as modulators of hemostasis. The invention also relates to methods and compositions for the diagnosis and treatment of hemostatic disorders, including, but not limited to, hemorrhagic disorders and thrombotic disorders. The present invention describes methods for the diagnostic evaluation and prognosis of various hemostatic conditions, and for the identification of subjects exhibiting a predisposition to such conditions. In addition, the present invention provides methods for the diagnostic monitoring of patients undergoing clinical evaluation for the treatment of a hemostatic or vascular disorders, and for monitoring the efficacy of compounds in clinical trials.
    Type: Application
    Filed: May 17, 2001
    Publication date: March 14, 2002
    Inventors: Denisa D. Wagner, Patrick Andre, Daqing W. Hartwell, Ingrid Hrachovinova